Full-Time
Eye care products and vision solutions
No salary listed
Cologne, Germany
In Person
See people who can refer or advise you
Alcon provides eye care products and vision solutions to improve how people see. It develops and manufactures devices and consumables for eye health, including cataract surgery equipment and intraocular lenses, retinal health therapies, and contact lenses, distributed through eye care professionals, hospitals, and consumers. The products work by supporting eye surgery, protecting and restoring vision, or correcting vision with lens-based options, backed by research and development and a global distribution network. Alcon differentiates itself with a broad, end-to-end portfolio across the eye care continuum, a strong emphasis on research and development, strategic partnerships with healthcare providers, and a commitment to diversity and inclusion. Its goal is to enhance vision and quality of life by delivering reliable, high-quality eye care solutions and advancing the science of eye health.
Company Size
10,001+
Company Stage
IPO
Headquarters
Geneva, Switzerland
Founded
1945
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Medical, dental, & vision coverage
HSA Medical Plan
PTO
Paid Parental leave
401k
Retirement Plan Company Contribution
Low payroll deductions
Tuition Reimbursement Program
Annual Bonus
Free Family Contact Lens Program
12 Company Paid Holidays
Alcon reported Q2 revenues of approximately $2.8bn, marking an 8% year-over-year increase. The Swiss eyecare company raised its 2026 earnings growth outlook to 12–15% per diluted share, up from 10–13% previously, whilst maintaining its sales growth forecast at 5–7%. The surgical segment generated around $1.6bn in Q2, up 8% year-over-year, whilst vision care brought in approximately $1.2bn, also up 8%. Operating income fell to $11m from $247m last year after Alcon took a $402m pre-tax charge to discontinue intraocular lens programmes acquired from PowerVision in 2019, citing unacceptable patient outcomes. CEO David Endicott attributed the strong performance to recent product launches, including the PanOptix Pro trifocal IOL. Alcon's shares rose approximately 2% to $75.10 in pre-market trading.
Alcon has raised its full-year profit guidance and revised down its tariff impact estimate to $40 million to $90 million, from $100 million to $150 million previously, after anticipating a $60 million refund from the US government. The US represents 45% of the Swiss-American eye care company's net sales. The company now expects its core operating profit margin to rise 90 to 190 basis points in 2026, up from 70 to 170 basis points. Core diluted earnings per share growth guidance was also increased to 12% to 15%, from 10% to 13%. Second-quarter net sales rose to $2.78 billion from $2.58 billion year-on-year, beating analyst expectations. Adjusted earnings per share reached $0.84, surpassing the $0.75 estimate.
Alcon - 218,395 breached accounts. 2026-08-09 14:08 In August 2026, the Alcon eye care company was named in a ShinyHunters "pay or leak" extortion campaign. The group subsequently published data allegedly sourced from Alcon containing 218k unique email addresses along with other largely corporate B2B contact fields, including name, phone number and physical address. Read the original article: In June 2026, Inter-Con Security was targeted in a ShinyHunters "pay or leak" extortion campaign. The group subsequently published data it alleged was... Secure email service August 6, 2026 In June 2026, telecommunications tower infrastructure company American Tower was the target of a ShinyHunters "pay or leak" extortion campaign. The group subsequently published data allegedly taken from the company containing more than 200k unique email addresses belonging to employees, contractors, customers, and leads. Exposed data also included names, addresses,... June 26, 2026 In July 2026, electronic test and measurement equipment company Fluke was targeted in a ShinyHunters "pay or leak" extortion campaign. The group subsequently published more than 100GB of data allegedly taken from the company. The corpus contained largely corporate contact information, including over 800k unique email addresses, names, phone numbers... July 15, 2026
Ransomware Group shinyhunters hits: Alcon Inc. HookPhish team Target organization Alcon Inc. alcon.com Healthcare Summary. In the latest cybersecurity news, Alcon Inc. - an organization based in CH - has fallen victim to a ransomware attack conducted by the group shinyhunters. This data breach, discovered on Aug 2, 2026, 00:00 UTC, underscores the increasing need for proactive cybersecurity defenses as HookPhish continue through 2026. Incident report. | Target Organization | Alcon Inc. | | Threat Group | shinyhunters | | Summary | Over 25 million Salesforce records containing some PII was compromised. This is a final warning to reach out by 4 August 2026 before HookPhish leak along with several annoying (digital) problems that'll come your way. Make the right decision, don't be the next headline. | | Date of Breach | Aug 1, 2026, 00:00 UTC | | Discovery Date | Aug 2, 2026, 00:00 UTC | | Region | CH | | Target Domain | alcon.com | | Business Sector | Healthcare | How to reduce your ransomware risk. Most ransomware intrusions start with a stolen password or a phishing email. A few proactive steps sharply cut your exposure: * real-time breach alerts - close the gap attackers exploit. * phishing simulations - close the gap attackers exploit. Disclaimer. HookPhish does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.
Aravind Eye Care System and Alcon launch Global Centre of Excellence for retina Training in Coimbatore, India. Jul 24, 2026, 09:00 ET * Second Centre of Excellence expands Alcon and Aravind's partnership to strengthen Retina care training * Dedicated training hub will help expand access to advanced retina care COIMBATORE, India, July 24, 2026 /CNW/ - Aravind Eye Care System and Alcon, Global Leader in Eye Care today announced the launch of the Aravind Alcon Global Centre of Excellence (CoE) for Vitreoretinal Surgery Training in Coimbatore. Building on the successful launch of the Global Cataract Centre of Excellence in 2024, the new Centre marks the second phase of Aravind & Alcon's Partnership to address one of the most critical gaps in global eye care - access to retina training. The dedicated Vitreoretinal Centre of Excellence will strengthen surgical capability by equipping ophthalmologists with advanced retina training and expanding access to quality eye care in underserved regions. While cataract care has scaled effectively, retina care remains limited due to a shortage of trained specialists, particularly across Africa, Latin America and parts of Asia. Established within Aravind Eye Care System, the Centre is designed as a global training hub that combines hands-on surgical training with scalable virtual education, focusing on practical surgical capability and long-term capacity building. The Centre also features a state-of-the-art wet laboratory for vitreoretinal training and will initially train approximately 60 participants annually, while also extending its reach through virtual fellowship programmes. Speaking on the occasion, Mr. Raj Narayanan, Senior Vice President and President International, Alcon said, "For more than two decades, Alcon and Aravind have partnered to advance surgical education and help strengthen eye care around the world. The inauguration of this new Global Centre of Excellence in Retina marks an important step in our shared commitment to developing the next generation of eye care professionals through world-class training and capability building. We are proud to continue a partnership that is helping improve patient outcomes and expand access to high-quality eye care globally." Dr. Narendran, Chief Medical Officer, Aravind Eye Care Hospital, Coimbatore, said: "At Aravind Eye Care System, training has been central to our mission of eliminating needless blindness from the beginning. For more than two decades, our partnership with Alcon has helped us translate this commitment into world-class surgical education. We are proud that Aravind Eye Hospital, Coimbatore, is now home to India's first Global Center of Excellence in Retina. This comes at a critical time, as retinal disease is an increasingly common cause of vision loss in India and worldwide, and the need for skilled retinal surgeons continues to grow. The center provides the next generation of ophthalmologists with a structured, hands-on pathway to master complex procedures with precision and confidence. Together with Alcon, we look forward to strengthening eye care, improve patient outcomes, and expand access to quality treatment for all who need it." Aravind Eye Care System is recognised globally for delivering high-quality eye care alongside world-class medical education and knowledge transfer. The new Centre will advance vitreoretinal training by helping strengthen surgical capabilities and improve access to retina care across regions where specialist retina services remain scarce. By combining hands-on training with scalable virtual education, the initiative aims to build long-term healthcare capacity and support better patient outcomes worldwide. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com. SOURCE Alcon Media Relations: Edelman India | Ritika Dutt | [email protected]; Alcon | Bree Bovay | [email protected]